Testing the efficacy of new pharmaceutical candidates for APBD

Awardee: Or Kakhlon

Institution: Research Fund of the Hadassah Medical Organization

Award Amount: $52,509

Previous
Previous

What are the functional consequences of CDKL5 dysfunction in human neuronal cells?

Next
Next

Gene Therapy for Adult Polyglucosan Body Disease (APBD)